Psychosocial and Quality of Life in Women Receiving the 21-Gene Recurrence Score Assay: The Impact of Decision Style in Women with Intermediate RS

Multigene assays such as the 21-gene recurrence score (RS) quantify risk for recurrence and potential benefit from chemotherapy in early-stage, ER+ breast cancers. Few studies have assessed the impact of testing on patient-reported outcomes such as cancer-related distress or quality of life. The few...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Sulayman, Nadiyah, Spellman, Elizabeth, Graves, Kristi D., Peshkin, Beth N., Isaacs, Claudine, Schwartz, Marc D., O'Neill, Suzanne C.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2012
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3413972/
https://ncbi.nlm.nih.gov/pubmed/22899924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/728290
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires